Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: ChemMedChem. 17(9)
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (who)
-
Universitätsbibliothek Leipzig
- (when)
-
2023
- Creator
-
Schäker-Hübner, Linda
Haschemi, Reza
Büch, Thomas
Kraft, Fabian B.
Brumme, Birke
Schöler, Andrea
Jenke, Robert
Meiler, Jens
Aigner, Achim
Bendas, Gerd
Hansen, Finn Kristian
- URN
-
urn:nbn:de:bsz:15-qucosa2-868564
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schäker-Hübner, Linda
- Haschemi, Reza
- Büch, Thomas
- Kraft, Fabian B.
- Brumme, Birke
- Schöler, Andrea
- Jenke, Robert
- Meiler, Jens
- Aigner, Achim
- Bendas, Gerd
- Hansen, Finn Kristian
- Universitätsbibliothek Leipzig
Time of origin
- 2023
Other Objects (12)
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Structure-based design of inhibitors of the zinc-dependent enzymes histone deacetylase (HDAC) and UDP-3-O-(R-3-hydroxymyristoylyl)-N-acetylglucosamine deacetylase (LpxC)
Development of dual BET/HDAC inhibitors
Rolle der Histondeacetylase (HDAC) in humanen soliden Tumoren
CIK Cells and HDAC Inhibitors in Multiple Myeloma
Epigenetische Regulierung und HDAC Inhibition von kolorektalen Karzinomen
Total synthesis of natural HDAC inhibitors and derivatives thereof
Wirkungen des HDAC-Inhibitors Valproinsäure auf den Tumorsuppressor PTEN
Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A
Neue Kombinationstherapien mit Klasse-I-HDAC-Inhibitoren für das Urothelkarzinom
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Structure-based design of inhibitors of the zinc-dependent enzymes histone deacetylase (HDAC) and UDP-3-O-(R-3-hydroxymyristoylyl)-N-acetylglucosamine deacetylase (LpxC)
Development of dual BET/HDAC inhibitors
Rolle der Histondeacetylase (HDAC) in humanen soliden Tumoren
CIK Cells and HDAC Inhibitors in Multiple Myeloma
Epigenetische Regulierung und HDAC Inhibition von kolorektalen Karzinomen
Total synthesis of natural HDAC inhibitors and derivatives thereof
Wirkungen des HDAC-Inhibitors Valproinsäure auf den Tumorsuppressor PTEN
Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A
Neue Kombinationstherapien mit Klasse-I-HDAC-Inhibitoren für das Urothelkarzinom
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Structure-based design of inhibitors of the zinc-dependent enzymes histone deacetylase (HDAC) and UDP-3-O-(R-3-hydroxymyristoylyl)-N-acetylglucosamine deacetylase (LpxC)
Development of dual BET/HDAC inhibitors
Rolle der Histondeacetylase (HDAC) in humanen soliden Tumoren
CIK Cells and HDAC Inhibitors in Multiple Myeloma
Epigenetische Regulierung und HDAC Inhibition von kolorektalen Karzinomen
Total synthesis of natural HDAC inhibitors and derivatives thereof
Wirkungen des HDAC-Inhibitors Valproinsäure auf den Tumorsuppressor PTEN
Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A